SYNTHESIS AND ANALGESIC EFFECTS OF L]-1-OXO-2(R)-BENZYLPROPYL]-L-ISOLEUCYL-L-LEUCINE, A NEW POTENT INHIBITOR OF MULTIPLE NEUROTENSIN NEUROMEDIN-N DEGRADING ENZYMES
S. Doulut et al., SYNTHESIS AND ANALGESIC EFFECTS OF L]-1-OXO-2(R)-BENZYLPROPYL]-L-ISOLEUCYL-L-LEUCINE, A NEW POTENT INHIBITOR OF MULTIPLE NEUROTENSIN NEUROMEDIN-N DEGRADING ENZYMES, Journal of medicinal chemistry, 36(10), 1993, pp. 1369-1379
The synthesis of yl]-1-oxo-2(R)-benzylpropyl]-L-isoleucyl-L-leucine (J
MV-390-1, 6a), a multipeptidase inhibitor based on the C-terminal sequ
ence common to neurotensin (NT) and neuromedin N (NN), is described. T
his compound behaves as a full inhibitor of the major NT/NN degrading
enzymes in vitro, e.g. endopeptidase 24.16, endopeptidase 24.15, endop
eptidase 24.11, and leucine aminopeptidase (type IV-S), in the nanomol
ar range (IC50's from 30 to 60 nM). Compound 6a was found to increase
endogenous recovery of NT and NN from slices of mice hypothalamus depo
larized with potassium. In various assays commonly used to select anal
gesics, e.g. hot-plate test, tail-flick test, acetic acid-induced writ
hing test, in mice, compound 6a proved to be potent when intracerebrov
entricularly (icv) injected. The analgesic effects observed were total
ly (hot-plate test) or largely (tail-flick test) reversed by the opioi
d antagonist naltrexone. Furthermore, icv injection of compound 6a (10
mug/mouse) was found to significantly potentiate the hypothermic effe
cts of NT or NN.